Nautilus Biotechnology, Inc. (NAUT)
2.735
-0.40
(-12.90%)
USD |
NASDAQ |
Oct 30, 16:00
2.73
0.00 (0.00%)
After-Hours: 19:10
Nautilus Biotechnology Enterprise Value : 339.98M for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 339.98M |
| October 28, 2026 | 348.89M |
| October 27, 2026 | 308.14M |
| October 26, 2026 | 250.85M |
| October 23, 2026 | 352.71M |
| October 22, 2026 | 271.22M |
| October 21, 2026 | 285.23M |
| October 20, 2026 | 264.85M |
| October 19, 2026 | 275.04M |
| October 16, 2026 | 202.46M |
| October 15, 2026 | 215.19M |
| October 14, 2026 | 215.19M |
| October 13, 2026 | 201.19M |
| October 12, 2026 | 216.47M |
| October 09, 2026 | 226.65M |
| October 08, 2026 | 171.90M |
| October 07, 2026 | 189.73M |
| October 06, 2026 | 165.54M |
| October 05, 2026 | 178.27M |
| October 02, 2026 | 189.73M |
| October 01, 2026 | 140.07M |
| September 30, 2026 | 120.97M |
| September 29, 2026 | 117.45M |
| September 28, 2026 | 85.00M |
| September 25, 2026 | 66.26M |
| Date | Value |
|---|---|
| September 24, 2026 | 69.80M |
| September 23, 2026 | 65.14M |
| September 22, 2026 | 70.93M |
| September 21, 2026 | 65.25M |
| September 18, 2026 | 66.68M |
| September 17, 2026 | 67.41M |
| September 16, 2026 | 67.46M |
| September 15, 2026 | 57.15M |
| September 14, 2026 | 59.09M |
| September 11, 2026 | 73.55M |
| September 10, 2026 | 69.69M |
| September 09, 2026 | 86.28M |
| September 08, 2026 | 61.84M |
| September 04, 2026 | 58.91M |
| September 03, 2026 | 60.77M |
| September 02, 2026 | 66.15M |
| September 01, 2026 | 61.66M |
| August 31, 2026 | 67.50M |
| August 28, 2026 | 56.47M |
| August 27, 2026 | 58.81M |
| August 26, 2026 | 63.05M |
| August 25, 2026 | 55.91M |
| August 24, 2026 | 55.14M |
| August 21, 2026 | 65.22M |
| August 20, 2026 | 58.58M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 53.27B |
| Bio-Rad Laboratories, Inc. | 10.03B |
| Bruker Corp. | 11.10B |
| Danaher Corp. | 188.80B |
| Harvard Bioscience, Inc. | 77.76M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.64M |
| Revenue (Quarterly) | 0.234M |
| Total Expenses (Quarterly) | 15.87M |
| EPS Diluted (Quarterly) | -0.1229 |
| Gross Profit Margin (Quarterly) | -467.5% |
| Profit Margin (Quarterly) | -6.68K% |
| Earnings Yield | -16.88% |
| Normalized Earnings Yield | -16.88 |